Migraine. Migraine
Conditions
Interventions
In the experimental group, before starting the study the questionnaire of disability due to headache (PedMIDAS) will be provided, then levetiracetam tablets 20 mg per kg body weight), is prescribed a
Treatment - Drugs
Sponsors
Vice chancellor for research, Kermanshah University of Medical Sciences
Eligibility
Sex/Gender
All
Age
4 Years to 14 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: diagnosis of migraine according to ICHD III; written and informed consent of the patient or his guardian. Exclusion criteria: patients with abnormal imaging studies or EEG; a history of recent head trauma or drug abuse; having a secondary headache to infection (sinusitis, of otitis media, ...); and patients who coincident suffered from seizures and mood disorders ; being abnormal neurological examination
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Headache frequency. Timepoint: Beginning of the study, 1 ,3 and 6 months after study. Method of measurement: With the question of patient.;The severity of migraine headaches. Timepoint: Beginning of the study, 1 ,3 and 6 months after study. Method of measurement: Based on questionnaire of determination of disability due to headache (PedMIDAS).;Duration of headaches. Timepoint: Beginning of the study, 1 ,3 and 6 months after study. Method of measurement: With the question of patient. | — |
Countries
Iran (Islamic Republic of)
Outcome results
None listed